Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$461M |
| 2 |
American Tower
AMT
|
+$401M |
| 3 |
State Street SPDR Portfolio Intermediate Term Corporate Bond ETF
SPIB
|
+$399M |
| 4 |
US Bancorp
USB
|
+$346M |
| 5 |
iShares Core MSCI EAFE ETF
IEFA
|
+$316M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Intel
INTC
|
+$589M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$506M |
| 3 |
Lockheed Martin
LMT
|
+$418M |
| 4 |
RTN
Raytheon Company
RTN
|
+$373M |
| 5 |
Procter & Gamble
PG
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.78% |
| 2 | Healthcare | 12.43% |
| 3 | Financials | 11.93% |
| 4 | Consumer Discretionary | 9.96% |
| 5 | Industrials | 8.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
American Coastal Insurance
ACIC
$515M
| $1.08M | ﹤0.01% |
137,719
+8,738
| +7% | +$70.9K |
|
|
CORR
2602
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $1.08M | ﹤0.01% |
117,544
-12,402
| -10% | -$156K |
|
2603
Precision BioSciences
DTIL
$180M
| $1.07M | ﹤0.01% |
4,296
+677
| +19% | +$148K |
|
2604
Personalis
PSNL
$1.35B
| $1.07M | ﹤0.01% |
82,575
+10,968
| +15% | +$122K |
|
2605
KALA BIO
KALA
$14.1M
| $1.07M | ﹤0.01% |
41
+18
| +78% | +$510K |
|
2606
Hackett Group
HCKT
$270M
| $1.06M | ﹤0.01% |
78,568
+2,262
| +3% | +$31.2K |
|
|
VXRT
2607
DELISTED
Vaxart
VXRT
| $1.06M | ﹤0.01% |
+120,182
| New | +$345K |
|
2608
iShares Select Dividend ETF
DVY
$23.5B
| $1.06M | ﹤0.01% |
13,170
-68,775
| -84% | -$5.49M |
|
|
MEET
2609
DELISTED
The Meet Group, Inc. Common Stock
MEET
| $1.06M | ﹤0.01% |
170,222
+86
| +0.1% | +$530 |
|
|
VWTR
2610
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $1.06M | ﹤0.01% |
125,751
+2,752
| +2% | +$22K |
|
|
GDEN
2611
DELISTED
Golden Entertainment
GDEN
| $1.06M | ﹤0.01% |
118,555
+7,362
| +7% | +$68.5K |
|
|
GTYH
2612
DELISTED
GTY Technology Holdings, Inc. Common Stock
GTYH
| $1.06M | ﹤0.01% |
253,786
+26,612
| +12% | +$104K |
|
|
BCEL
2613
DELISTED
Atreca, Inc. Class A Common Stock
BCEL
| $1.06M | ﹤0.01% |
49,624
+13,156
| +36% | +$232K |
|
2614
Donegal Group Class A
DGICA
$731M
| $1.05M | ﹤0.01% |
74,186
+6,400
| +9% | +$91.3K |
|
|
LITS
2615
Lite Strategy Inc
LITS
$32.8M
| $1.05M | ﹤0.01% |
12,745
+1,191
| +10% | +$72.2K |
|
|
LBC
2616
DELISTED
Luther Burbank Corporation Common Stock
LBC
| $1.05M | ﹤0.01% |
104,772
-298
| -0.3% | -$2.87K |
|
2617
Regional Management Corp
RM
$301M
| $1.04M | ﹤0.01% |
58,900
| – | – |
|
|
TACO
2618
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
| $1.03M | ﹤0.01% |
172,896
+101,793
| +143% | +$564K |
|
2619
Celsius Holdings
CELH
$7.47B
| $1.02M | ﹤0.01% |
260,517
+27,903
| +12% | +$65.8K |
|
|
AUD
2620
DELISTED
Audacy, Inc.
AUD
| $1.02M | ﹤0.01% |
737,606
-10,720
| -1% | -$15.2K |
|
2621
Bank First Corp
BFC
$1.69B
| $1.01M | ﹤0.01% |
15,801
+1,081
| +7% | +$62K |
|
2622
Replimune Group
REPL
$941M
| $1.01M | ﹤0.01% |
40,758
+8,264
| +25% | +$146K |
|
|
SNCR
2623
DELISTED
Synchronoss Technologies
SNCR
| $1.01M | ﹤0.01% |
31,787
+577
| +2% | +$15.9K |
|
|
CATC
2624
DELISTED
CAMBRIDGE BANCORP
CATC
| $1.01M | ﹤0.01% |
17,025
+5,623
| +49% | +$296K |
|
2625
Protagonist Therapeutics
PTGX
$8.79B
| $1.01M | ﹤0.01% |
57,072
+13,168
| +30% | +$165K |
|
Similar funds
Charles Schwab's Q2 2020 Portfolio in Review
As of Q2 2020, Charles Schwab held 3,435 positions worth $204B, up 20% from $170B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Charles Schwab's Q2 2020 filing shows 201 new, 1,862 increased, 1,124 reduced and 116 closed positions. Its largest new stake was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M. The largest sale was Intel, an estimated $589M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2020 buy was iShares Core MSCI EAFE ETF: 5,827,630 shares worth $333M.
- Charles Schwab added most to iShares Core S&P 500 ETF in Q2 2020, an estimated $461M increase.
- Charles Schwab's biggest Q2 2020 reduction was Intel, cutting an estimated $589M.
- Charles Schwab fully exited Raytheon Company in Q2 2020, selling an estimated $373M.
- Charles Schwab's ten largest holdings make up 17% of its $204B portfolio in Q2 2020.
- Charles Schwab opened 201 new positions and closed 116 in Q2 2020.
- Charles Schwab's portfolio value rose 20% quarter-over-quarter to $204B.
Based on Charles Schwab's 13F filing for Q2 2020, filed 14 Aug 2020.